Introduction
Inflammatory bowel disease (IBD) is a term used to describe disorders that involve chronic inflammation of digestive tract. 1 
Types of IBD include:
Ulcerative colitis: This condition causes longlasting inflammation and sores (ulcers) in the innermost lining of large intestine (colon) and rectum. Inflammatory bowel disease symptoms vary, depending on the severity of inflammation and where it occurs. Symptoms may range from mild to severe. Both ulcerative colitis and Crohn's disease usually involve severe diarrhea, abdominal pain, fatigue and weight loss. 4 Main aim is to reduce the inflammation that triggers signs and symptoms. Drug therapy and surgery is the sole treatment for IBD. First line treatment of IBD includes Anti-inflammatory drugs like corticosteroids and aminosalicylates such as olsalazine, balsalazide, mesalamine. 5, 6 Based on the area of colon that's affected the medications are given. Immunosuppressant drugs like azathioprine, mercaptopurine, cyclosporine and methotrexate are given. In addition antibiotics can be used when infection is a concern. Other medications and supplements include antidiarrheal medications, pain relievers, iron supplements, calcium and vitamin d supplements. [7] [8] [9] Surgery is adviced when conventional medical therapy had failed in IBD patients. Corticosteroids like prednisone, methylprednisolone and hydrocortisone are used in the treatment of IBD. [10] [11] [12] Frequent usage of steroids prior to surgery can lead to poor wound healing and infectious complications which has raised concerns regarding their potential impact on postoperative outcomes. Most of the studies show's that preoperative steroid use are associated with infectious or overall complications. Hospital, Annamalai University, Annamalai Nagar, Tamil Nadu. Study Period: The study was conducted for a period of three months (November 2018-January-2019).
Study Recruitment Procedures
 The recruitment of subjects was carried out with the help of physician who has the knowledge of patient's medical history.  The subjects selected were the patients who were treated as inpatients.  The study procedure was completely explained to the patients.  The patients included in the study were selected based on inclusion and exclusion criteria. During this study 102 patients were enrolled in which majority of patients were female (66.4%) than male (33.6%). The age-distribution of the study showed majority of patients fall under 30-40years of age group, accounting for about 50.9% and least among 20-30years of age, accounting for about 21.5%. 
Inclusion Criteria
 Patients who were treated as inpatients for the diagnosis of Inflammatory Bowel Disease.  Patients of both the gender.  Patients between 20-50yrs of age. Exclusion Criteria  Patients who are not willing to participate.  Patients who need emergency
Conclusion
In this study, among 102 patients considered, female patients were more (66.4%)compared to male patients (33.6%),who were in the age group ranging from 20-50 years. According to the age group most commonly affected age group patients were 30-40 years accounting for about 50.9%.It has also been found that the patients with IBD coexisted with disease like diabetes, anemia, renal & cardiac problems. 
